|
|
|
40
|
B4624
|
SYNJARDY 12.5/1 G TAB (STO/BOE)
|
EMPAGLIFLOZIN/METFORMIN
|
SYNJARDY
|
60'S
|
A
|
$67.25
|
$1.120
|
TABLET
|
60
|
TAB
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDENSTOKES LTD
|
B
|
682018
|
SODIUM-GLUCOSE CO-TRANSPORTER HIBITOR/BIGUANIDE
|
2022-10-31
|
2024-03-31
|
|
ORAL
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
|
40
|
B4811
|
VYMADA 24MG | 26MG TAB (NVS/COL) SACUBITRIL | VALSARTAN
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
$70.68
|
$2.52
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
B4812
|
VYMADA 49MG | 51MG TAB (NVS/COL) SACUBITRIL | VALSARTAN
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
$70.68
|
$2.52
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
B4813
|
VYMADA 97MG | 103MG TAB (NVS/COL) SACUBITRIL | VALSARTAN
|
SACUBITRIL|VALSARTAN
|
VYMADA
|
28'S
|
B
|
$70.68
|
$2.52
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
243208
|
ANGIOTENSIN II RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
B4911
|
XOLAIR 150MG INJ (NVS/COL) OMALIZUMAB
|
OMALIZUMAB
|
XOLAIR
|
150MG VIAL
|
C
|
1,304.93
|
1,304.93
|
INJECTION
|
0
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
4810
|
RESPIRATORY INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
40
|
B4913
|
OMALIREL 150MG INJ (RLS/AHI) OMALIZUMAB
|
OMALIZUMAB
|
OMALIREL
|
150MG VIAL
|
C
|
$844.86
|
$844.86
|
INJECTION
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4810
|
RESPIRATORY INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
40
|
B5012
|
ANORO ELLIPTA 55/22 INHR (GSK/COL) UMECLIDINI
|
UMECLIDINIUM|VILANTEROL
|
ANORO ELLIPTA
|
30 DOSES
|
BQ
|
$141.60
|
$141.60
|
INHALER
|
1
|
INHR
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
40
|
B521E
|
SAFEBO 62.5MG TAB (MSN/ATB)
|
BOSENTAN
|
SAFEBO
|
60'S
|
BQ
|
$163.10
|
$2.72
|
TABLET
|
0
|
TAB
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
4848
|
VASODILATING AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
40
|
B521F
|
PMS-BOSENTAN 125MG TAB (PMS/COL)
|
BOSENTAN
|
PMS-BOSENTAN
|
60'S
|
BQ
|
$339.79
|
$5.66
|
TABLET
|
0
|
TAB
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
4848
|
VASODILATING AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
40
|
B5312
|
CANCIDAS 50MG INJ (MSD/STO) CASPOFUNGIN
|
CASPOFUNGIN
|
CANCIDAS
|
50MG VIAL
|
C
|
$712.77
|
$712.77
|
INJECTION
|
0
|
VIAL
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
081416
|
ECHINOCANDINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
B5319
|
CASPOGIN 50MG INJ (CIP/AHI) CASPOFUNGIN
|
CASPOFUNGIN
|
CASPOGIN
|
10ML VIAL
|
BQ
|
$335.28
|
$335.28
|
INJECTION
|
0
|
VIAL
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081416
|
ECHINOCANDINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
B5831
|
APO-NABILONE 1MG CAP (APO/COL)
|
NABILONE
|
APO-NABILONE
|
50'S
|
A
|
$66.00
|
$1.32
|
CAPSULE
|
30
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
B5832
|
APO-NABILONE 0.25MG CAP (APO/COL)
|
NABILONE
|
APO-NABILONE
|
50'S
|
A
|
$23.05
|
$0.46
|
CAPSULE
|
30
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
B5911
|
AMLOTENSIVE CT 5MG | 25MG TAB (CAR/COL) AMLODIPINE | CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
$26.26
|
$0.13
|
TABLET
|
60
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
B5921
|
AMLOTENSIVE CT 5MG | 50MG TAB (CAR/COL) AMLODIPINE | CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
$35.90
|
$0.17
|
TABLET
|
30
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-07-11
|
2024-03-31
|
Add to Contract as Cat A
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-07-11
|
|
|
|
40
|
B5931
|
AMLOTENSIVE CT 10MG | 25MG TAB (CAR/COL) AMLODIPINE | CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
$26.26
|
$0.13
|
TABLET
|
30
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-07-11
|
2024-03-31
|
Add to Contract as Cat A
|
oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-07-11
|
|
|
|
40
|
B5941
|
AMLOTENSIVE CT 10MG | 50MG TAB (CAR/COL) AMLODIPINE | CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
$35.90
|
$0.17
|
TABLET
|
30
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-07-11
|
2022-03-31
|
Add to Contract as Cat A
|
oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-07-11
|
|
|
|
0
|
Brand C
|
Brand Name
|
Active Ingredient
|
Trade Name
|
Package Si
|
Fo
|
Pkg Price
|
Unit Pric
|
Unit Descrip
|
|
Pack
|
Man
|
Manufacturer Name
|
Age
|
Agent Name
|
B
|
Therapeu
|
Therapeutic Desc
|
|
|
Status Description
|
Default Route
|
0
|
Therapeutic Head
|
|
